Fingerprint
Dive into the research topics of 'Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
Hervé Avet-Loiseau*, Rafael Fonseca, David Siegel, Meletios A. Dimopoulos, Ivan Špička, Tamás Masszi, Roman Hájek, Laura Rosiñol, Vesselina Goranova-Marinova, Georgi Mihaylov, Vladimír Maisnar, Maria Victoria Mateos, Michael Wang, Ruben Niesvizky, Albert Oriol, Andrzej Jakubowiak, Jiri Minarik, Antonio Palumbo, William Bensinger, Vishal Kukreti
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
106
Scopus
citations